Comment by
HomerAndCompany on Dec 29, 2023 8:42am
It surprises me that the public offering of Dec 27, 2023 was not priced higher given the insider appetite for shares at $12.95 in August. The offering price was disapointing to me. The "healthcare focused institutional investors" are likely to hold their shares for a substantian gain. Should this US$20,000,000 carry Profound through to profitabilty?
Comment by
rocko65 on Dec 29, 2023 11:30am
yes agreed, pretty shocked at the offering price. Why would they take a 30% hit on shares they just bought in August if things were so good? I guess we dont know what goes on in the negotiations for these placements but this sucks